Physician-Scientist Steven Quay and an International Team of Scientists and Investigators Provide Science-Based Analysis of the Origin of COVID-19 to the US CongressPRNewsWire • 07/15/21
Atossa Therapeutics Receives Regulatory Approval To Open Clinical Study of AT-H201 in AustraliaGlobeNewsWire • 07/07/21
Quant System Highlight: Investors Following This Are Up 120% In A Month! (Video)Seeking Alpha • 06/24/21
ATOS Stock: How Redditors and a June 28 Catalyst Are Squeezing Atossa TherapeuticsInvestorPlace • 06/24/21
A tiny biotech company focused on breast cancer treatments has soared 29% amid Reddit hypeBusiness Insider • 06/22/21
Atossa Therapeutics Set to Be Included in the Russell 2000 and Russell 3000 IndexesGlobeNewsWire • 06/16/21
Atossa Therapeutics Receives Approval from Swedish Regulators to Initiate Phase 2 Clinical Study of Oral Endoxifen to Reduce Mammographic Breast DensityGlobeNewsWire • 06/11/21
Atossa Therapeutics Reveals Final Endoxifen Data From Mid-Stage Breast Cancer TrialBenzinga • 06/09/21
Atossa Therapeutics Announces Final Data from Phase 2 Endoxifen Breast Cancer Study Primary Endpoint Met: 65.1% Reduction in Biomarker Ki-67; Secondary Endpoint Met: Endoxifen Safe and Well ToleratedGlobeNewsWire • 06/09/21